News & AnalysisBIOMEDICAL RESEARCH POLICY

NIH Funding Shifts With Disease Lobbying, Study Suggests

+ See all authors and affiliations

Science  12 Oct 2012:
Vol. 338, Issue 6104, pp. 181
DOI: 10.1126/science.338.6104.181

You are currently viewing the summary.

View Full Text

Summary

The growing power and influence of disease lobbying groups over the past 2 decades have dramatically reshaped the priorities of the U.S. National Institutes of Health (NIH), according to a new analysis. The study, which has drawn some skepticism, finds that the more money a group spent on lobbying, the more NIH boosted its spending on that disease.